Health topics

Innovative diagnostics for life-changing decisions from a partner you can trust.

Roche's commitment to advanced diagnostic solutions

Early and accurate diagnosis is crucial in the management and treatment of various health conditions. Our innovative diagnostic solutions address a wide range of health topics, with a special focus on cardiometabolic diseases, infectious diseases, neurology, oncology, and women's health.

By integrating cutting-edge technology with clinical expertise, we strive to provide healthcare professionals with the tools they need to make informed decisions, helping to ensure better health outcomes for patients worldwide.

Our extensive portfolio includes advanced testing methods and diagnostic tools that deliver precise and reliable results across diverse healthcare settings. Roche’s commitment to quality and innovation ensures that we remain at the forefront of diagnostic science, continuously improving and expanding our offerings to meet the evolving needs of healthcare providers and patients alike.

Enhancing patient care for a diverse range of health topics

Roche Diagnostics offers a wide range of diagnostic tools designed to address a wide range of health topics and challenges. Our advanced technology enables accurate detection, monitoring, and management of diseases, ensuring that healthcare professionals can provide timely and effective interventions. From routine screenings to complex diagnostic needs, our solutions are tailored to enhance patient care across various medical fields.

Your partner in enhancing healthcare

Our dedication goes beyond providing diagnostic tools. We collaborate closely with healthcare providers, offering support and expertise to optimize laboratory operations and improve clinical outcomes. With over a century of experience, Roche is a trusted partner in the global fight against disease, continually pushing the boundaries of what’s possible in medical diagnostics and innovating solutions that touch every stage of the patient journey.

A comprehensive portfolio of innovative infectious diseases solutions - committed to working  towards eliminating infectious diseases and helping to improve patient care.

No products found for this filter.

Innovative solutions to help navigate life-changing oncology decisions and elevate cancer care outcomes.

The cobas® PIK3CA Mutation Test is a real-time PCR test for the qualitative detection and identification of 17 mutations in exons 2, 5, 8, 10 and 21 in the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PIK3CA) in DNA isolated from formalin-fixed paraffin-embedded tumor tissue (FFPET). The cobas® PIK3CA Mutation Test is a real-time PCR test for use on the cobas® 4800 System intended to be used to identify patients with metastatic breast cancer whose tumors harbor these mutations.
GAAD is an in vitro diagnostic multivariate index assay intended to provide a semi-quantitative result by combining in an algorithm the quantitative measurements of Elecsys AFP assay and Elecsys PIVKA‑II assay in human serum and plasma with gender and age.GAAD is intended as an aid in diagnosis of Hepatocellular Carcinoma (HCC) (early and all stages). GAAD is indicated for adults who meet the following criteria: diagnosis of chronic liver disease and recommended for surveillance due to increased risk of developing HCC. GAAD must be interpreted in conjunction with other diagnostic findings and clinical information in accordance with standard clinical management guidelines.

Contact us

Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.